Drug class

Topical Immunomodulator - Imidazoquinolinamines

Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity. Read more about Topical Immunomodulator - Imidazoquinolinamines

16 drugs in this class 8 manufacturers

Advertisement

Drugs in Topical Immunomodulator - Imidazoquinolinamines

Showing 1–9 of 16 drugs

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES · EXTERNAL CONDYLOMATA ACUMINATA ·+2
GLENMARK PHARMA

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES · EXTERNAL CONDYLOMATA ACUMINATA ·+2
TARO PHARM USA

IMIQUIMOD

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES · EXTERNAL CONDYLOMATA ACUMINATA ·+1
OCEANSIDE PHARM

ZYCLARA (imiquimod)

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES · EXTERNAL CONDYLOMATA ACUMINATA ·+1
Bausch Health US

ZYCLARA (imiquimod)

TOPICAL IMMUNOMODULATOR - IMIDAZOQUINOLINAMINES · EXTERNAL CONDYLOMATA ACUMINATA ·+1
Bausch Health US
Filter & compare in the drug finder → Opens the drug finder with Topical Immunomodulator - Imidazoquinolinamines preselected. Add indication or manufacturer filters there.

About Topical Immunomodulator - Imidazoquinolinamines.

Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity.

They act primarily as Toll-like receptor 7 agonists, triggering dendritic cells and macrophages to produce interferon-alpha and other proinflammatory cytokines that induce apoptosis of diseased cells and clear lesions.

Clinically, these agents are utilized in dermatologic conditions, including external genital and perianal warts caused by human papillomavirus, actinic keratosis, and superficial basal cell carcinoma.